Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA9 | Q16790 | 2/20 | 0.34 |
| ▸ | KCNH2 | Q12809 | 8/20 | 0.34 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.33 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.33 |
| ▸ | KDM5A | P29375 | 1/20 | 0.33 |
| ▸ | KDM4C | Q9H3R0 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27306775 | 0.85 | MME (0.33) | KCNH2 | |
| SCHEMBL24619672 | 0.82 | CHRM2 (0.30) | — | |
| SCHEMBL25289174 | 0.81 | DNM1 (0.44) | CA12CA1CA9KCNH2 | |
| SCHEMBL25284630 | 0.81 | DNM1 (0.44) | CA12CA1CA9KCNH2 | |
| SCHEMBL29411339 | 0.81 | DNM1 (0.44) | CA12CA1CA9KCNH2 | |
| SCHEMBL25237690 | 0.81 | DNM1 (0.44) | CA12CA1CA9KCNH2 | |
| SCHEMBL25282561 | 0.81 | DNM1 (0.44) | CA12CA1CA9KCNH2 | |
| SCHEMBL25274424 | 0.81 | DNM1 (0.44) | CA12CA1CA9KCNH2 | |
| Hydrochloric Acid SCHEMBL25281560 | 0.79 | DNM1 (0.46) | CA12CA1CA9KCNH2 | |
| Hydrochloric Acid SCHEMBL25239096 | 0.79 | DNM1 (0.46) | CA12CA1CA9KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7960554-B2 | Ambient-temperature molten salts and process for producing the same | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2011-06-14 | — | — | US | disclosed |
| US-7534509-B2 | Ambient-temperature molten salts and process for producing the same | TOYOTA JIDOSHA KABUSHIKI KAISHA (JP) | 2009-05-19 | — | — | US | disclosed |
| US-20070225503-A1 | Ambient-temperature molten salts and process for producing the same | TOYOTA JIDOSHA KABUSHIKI KAISHA | 2007-09-27 | — | — | US | disclosed |
| US-20070203345-A1 | Ambient-temperature molten salts and process for producing the same | TOYOTA JIDOSHA KABUSHIKI KAISHA | 2007-08-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070203345-A1 | Ambient-temperature molten salts and process for producing the same | AFF1, AFF2, AFF4 | CA12 1999/4885CA1 1224/4885CA9 2212/4885 |
| US-20070225503-A1 | Ambient-temperature molten salts and process for producing the same | AFF1, AFF2, AFF4 | CA12 1999/4885CA1 1224/4885CA9 2212/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.